Emergent BioSolutions - M&A Summary and Business Overview

Healthcare ServicesCompany

Emergent BioSolutions M&A Summary

Emergent BioSolutions has acquired 11 companies. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.

Emergent BioSolutions’ largest acquisition to date was in 2018, when it acquired Adapt Pharma Operations for $735M. Emergent BioSolutions has acquired in 4 different US states, and 5 countries. The Company’s most targeted sectors include life science (64%) and medical products (19%).

Emergent BioSolutions Business Overview

Where is Emergent BioSolutions headquartered?

Emergent BioSolutions is headquartered in Gaithersburg, Maryland.

What is Emergent BioSolutions’ revenue?

Emergent BioSolutions disclosed revenue of 1,023M USD for 2023 and 1,076M USD for 2022.

How many employees does Emergent BioSolutions have?

Emergent BioSolutions has 1,600 employees.

What sector is Emergent BioSolutions in?

Emergent BioSolutions is a healthcare services company.

When was Emergent BioSolutions founded?

Emergent BioSolutions was founded in 1998.

M&A Summary

  • M&A Total Activity12
    • M&A Buy Activity11
    • M&A Sell Activity1
  • Total Sectors Invested 3
  • Total Countries Invested 5
  • M&A Buy/Sell Connections 9
  • M&A Advisors 7

Emergent BioSolutions

Emergent BioSolutions, Inc.

400 Professional Drive, Suite 400,
Gaithersburg, Maryland 20879
United States,
(240) 631-3200
www.emergentbiosolutions.com

Emergent BioSolutions is a specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Emergent BioSolutions was founded in 1998 and is based in Gaithersburg, Maryland.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 11 - - - - - 11
vol $1.3B $1.3B
Sell (0.0/yr) # 1 - - - - - 1
  12

Most Recent M&A

Company Date Value Type
Adapt Pharma Operations Ltd. 2018-08-28 735M USD Add-on Acquisition
Dublin 2, Ireland · www.adaptpharma.com
PaxVax, Inc. 2018-08-09 - Add-on Acquisition
Redwood City, California · www.paxvax.com
GlaxoSmithKline plc - Raxibacumab 2017-07-19 130M USD Divestiture
Brentford, United Kingdom
Emergent BioSolutions - Plasma Collection Facility 2015-05-28 - Divestiture
Winnipeg, Manitoba
Evolva Holding - EV-035 2014-12-17 - Divestiture
, Switzerland
Cangene Corp. 2014-02-21 222M USD Add-on Acquisition
Winnipeg, Manitoba · www.cangene.com
Bracco - Healthcare Protective Products Division 2013-08-02 26M USD Divestiture
, United States
TenX BioPharma - Monoclonal Antibody Cancer Therapy 2011-06-06 6M USD Divestiture
, United States
Trubion Pharmaceuticals, Inc. 2010-10-28 136M USD Add-on Acquisition
Seattle, Washington · www.trubion.com
MdBio Foundation - Foot Manufacturing Facility 2009-11-13 8M USD Divestiture
, United States
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 7 (64%) 963M (76%) 1 (100%) -
Healthcare Services 2 (18%) 266M (21%) - -
Medical Products 2 (18%) 34M (3%) - -
Total 11 $1.3B 1 -

By Geo

State/Country Buy Value Sell Value
United States 7 175M - -
  Washington 1 136M - -
  Connecticut 1 - - -
  California 1 - - -
Canada 1 222M 1 -
  Manitoba 1 222M 1 -
Ireland 1 735M - -
Switzerland 1 - - -
United Kingdom 1 130M - -
Domestic 7 (64%) 175M (14%) - -
Cross-border 4 (36%) 1.1B (86%) 1 (100%) -
Total 11 $1.3B 1 -

Top M&A Advisors

Financial Deals
BofA Securities
1
Morgan Stanley
1
Wedbush Securities, Inc.
1
Legal Deals
Covington & Burling
2
McCarthy Tétrault
1
DLA Piper
1

Deal Values

buy # Total
$100M to $1B 4 $1.2B
< $100M 3 $40M
TOTAL $1.3B
Largest Adapt Pharma Operations Ltd.
$735M (2018-08-28)

M&A Connections

Deals
Acquired from
Investor(s)
18%
2 (18%)
Strategic(s)
55%
6 (55%)
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.